search
Back to results

Healthy Outcomes for Muscle With Exercise in T1D (HOME T1D)

Primary Purpose

Diabetes Mellitus, Type 1

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Exercise
De-training
Sponsored by
McMaster University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Diabetes Mellitus, Type 1

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Age of 18-30 or 45-65 Sedentary or recreationally active, as defined by self-reported activity levels below the recommended 150-minute minimum of moderate-to-vigorous intensity physical activity per week Exclusion Criteria: Chronic use of anti-inflammatory, glucocorticoid, or other pain-relief medication History of daily cannabis, tobacco, or nicotine use within six months of study initiation BMI >30kg/m2 Prediabetes Type 2 diabetes Health conditions that put the subject at risk to participate in exercise during this study Atypical or Grade 2b diabetic sensorimotor polyneuropathy More than one lifetime event of hospitalization for diabetic ketoacidosis

Sites / Locations

  • McMaster UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

Twelve-week Exercise

One-week Detraining

Four-week Re-training

Arm Description

Study participants will participate in an exercise program consisting of aerobic and resistance exercise. This arm will last twelve weeks.

Study participants will undergo unilateral knee immobilization for a one-week period.

Study participants will once again participate in an exercise program consisting of aerobic and resistance exercise. This arm will last four weeks.

Outcomes

Primary Outcome Measures

The effect of T1D on skeletal muscle health, quantified by physiological parameters (detailed in description)
Individuals with T1D as well as their age, sex, and BMI-matched control counterparts will undergo various physiological assessments to evaluate their muscle health: strength/aerobic fitness testing, compartmental body composition assessment, blood analysis, glucose monitoring, muscle biopsy, motor neuron function evaluation, and assessments of muscle microvascular structure and function. All metrics will be compared between individuals with T1D and their non-T1D counterparts.

Secondary Outcome Measures

The effect of twelve weeks of exercise on skeletal muscle health compared to baseline, quantified by physiological parameters (detailed in description)
Following baseline assessments, study participants will undergo a combined aerobic and resistance training program for twelve weeks. Following twelve weeks of participation in this exercise program, all study participants will undergo various physiological assessments to evaluate their muscle health: strength/aerobic fitness testing, compartmental body composition assessment, blood analysis, glucose monitoring, muscle biopsy, motor neuron function evaluation, and assessments of muscle microvascular structure and function.
The acute effect of a detraining period on skeletal muscle health compared to baseline, quantified by physiological parameters (detailed in description)
Following completion of the aforementioned twelve week exercise program, study participants will undergo a seven-day detraining period consisting of unilateral knee immobilization using a hinged knee-joint immobilization brace. Immediately following this immobilization period, all study participants will undergo various physiological assessments to evaluate their muscle health: strength/aerobic fitness testing, compartmental body composition assessment, blood analysis, glucose monitoring, muscle biopsy, motor neuron function evaluation, and assessments of muscle microvascular structure and function.
The effect of a detraining period on skeletal muscle health compared to baseline, quantified by physiological parameters (detailed in description)
Following completion of the aforementioned twelve week exercise program, study participants will undergo a seven-day detraining period consisting of unilateral knee immobilization using a hinged knee-joint immobilization brace. Four weeks after this immobilization period, all study participants will undergo various physiological assessments to evaluate their muscle health: strength/aerobic fitness testing, compartmental body composition assessment, blood analysis, glucose monitoring, muscle biopsy, motor neuron function evaluation, and assessments of muscle microvascular structure and function.

Full Information

First Posted
January 25, 2023
Last Updated
October 18, 2023
Sponsor
McMaster University
search

1. Study Identification

Unique Protocol Identification Number
NCT05740514
Brief Title
Healthy Outcomes for Muscle With Exercise in T1D
Acronym
HOME T1D
Official Title
Targeting Vascular and Skeletal Muscle Health to Improve Quality of Life in Males and Females With Type 1 Diabetes
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 1, 2023 (Actual)
Primary Completion Date
December 2027 (Anticipated)
Study Completion Date
December 2028 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
McMaster University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Over 300,000 people in Canada suffer from Type 1 Diabetes (T1D), a chronic condition whose incidence rate has been increasing in Canada every year by 5.1% (higher than the global average). While exogenous insulin injections allow those with T1D to live, it is not a cure, and those with T1D develop severe complications (kidney failure, cardiovascular disease). Strategies to regress the development of these complications, minimize healthcare system burden, and save the lives of Canadians are urgently needed. Undertaking regular exercise is an obvious strategy for those with T1D and has many well-established health benefits. Despite these benefits, adults with T1D exercise less frequently due to fear of severe hypoglycemia and a lack of knowledge of effective exercise strategies. Adding to this complexity, the investigators have recently shown that males and females elicit differential impairments in skeletal muscle metabolism in response to T1D. These differences may extend to the peripheral microvasculature and may lead to sexual dimorphism in the health benefits of exercise for those with T1D. Ultimately, developing a healthy muscle mass, including microvasculature, will help mitigate dysglycemic and dyslipidemic fluctuations and improve insulin sensitivity. The overarching purpose of this proposed study is to determine the impact of T1D on human skeletal muscle and its microvasculature over the lifespan in males and females, and its responses to exercise training and detraining.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 1

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Study subjects will participate in a twelve-week exercise program. Following this time, a one-week detraining period will ensue. Following this detraining period, study subjects will re-engage in a four-week exercise program.
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
168 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Twelve-week Exercise
Arm Type
Experimental
Arm Description
Study participants will participate in an exercise program consisting of aerobic and resistance exercise. This arm will last twelve weeks.
Arm Title
One-week Detraining
Arm Type
Experimental
Arm Description
Study participants will undergo unilateral knee immobilization for a one-week period.
Arm Title
Four-week Re-training
Arm Type
Experimental
Arm Description
Study participants will once again participate in an exercise program consisting of aerobic and resistance exercise. This arm will last four weeks.
Intervention Type
Behavioral
Intervention Name(s)
Exercise
Intervention Description
Exercise training.
Intervention Type
Behavioral
Intervention Name(s)
De-training
Intervention Description
Exercise de-training via unilateral knee immobilization.
Primary Outcome Measure Information:
Title
The effect of T1D on skeletal muscle health, quantified by physiological parameters (detailed in description)
Description
Individuals with T1D as well as their age, sex, and BMI-matched control counterparts will undergo various physiological assessments to evaluate their muscle health: strength/aerobic fitness testing, compartmental body composition assessment, blood analysis, glucose monitoring, muscle biopsy, motor neuron function evaluation, and assessments of muscle microvascular structure and function. All metrics will be compared between individuals with T1D and their non-T1D counterparts.
Time Frame
At time of study start (baseline characteristics)
Secondary Outcome Measure Information:
Title
The effect of twelve weeks of exercise on skeletal muscle health compared to baseline, quantified by physiological parameters (detailed in description)
Description
Following baseline assessments, study participants will undergo a combined aerobic and resistance training program for twelve weeks. Following twelve weeks of participation in this exercise program, all study participants will undergo various physiological assessments to evaluate their muscle health: strength/aerobic fitness testing, compartmental body composition assessment, blood analysis, glucose monitoring, muscle biopsy, motor neuron function evaluation, and assessments of muscle microvascular structure and function.
Time Frame
Twelve weeks following study initiation
Title
The acute effect of a detraining period on skeletal muscle health compared to baseline, quantified by physiological parameters (detailed in description)
Description
Following completion of the aforementioned twelve week exercise program, study participants will undergo a seven-day detraining period consisting of unilateral knee immobilization using a hinged knee-joint immobilization brace. Immediately following this immobilization period, all study participants will undergo various physiological assessments to evaluate their muscle health: strength/aerobic fitness testing, compartmental body composition assessment, blood analysis, glucose monitoring, muscle biopsy, motor neuron function evaluation, and assessments of muscle microvascular structure and function.
Time Frame
Thirteen weeks following study initiation
Title
The effect of a detraining period on skeletal muscle health compared to baseline, quantified by physiological parameters (detailed in description)
Description
Following completion of the aforementioned twelve week exercise program, study participants will undergo a seven-day detraining period consisting of unilateral knee immobilization using a hinged knee-joint immobilization brace. Four weeks after this immobilization period, all study participants will undergo various physiological assessments to evaluate their muscle health: strength/aerobic fitness testing, compartmental body composition assessment, blood analysis, glucose monitoring, muscle biopsy, motor neuron function evaluation, and assessments of muscle microvascular structure and function.
Time Frame
Seventeen weeks following study initiation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age of 18-30 or 45-65 Sedentary or recreationally active, as defined by self-reported activity levels below the recommended 150-minute minimum of moderate-to-vigorous intensity physical activity per week Exclusion Criteria: Chronic use of anti-inflammatory, glucocorticoid, or other pain-relief medication History of daily cannabis, tobacco, or nicotine use within six months of study initiation BMI >30kg/m2 Prediabetes Type 2 diabetes Health conditions that put the subject at risk to participate in exercise during this study Atypical or Grade 2b diabetic sensorimotor polyneuropathy More than one lifetime event of hospitalization for diabetic ketoacidosis
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Thomas J Hawke, PhD
Phone
905-525-9140
Ext
22372
Email
hawke@mcmaster.ca
First Name & Middle Initial & Last Name or Official Title & Degree
Irena A Rebalka, PhD
Phone
905-525-9140
Ext
26868
Email
rebalka@mcmaster.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas J Hawke, PhD
Organizational Affiliation
McMaster University
Official's Role
Principal Investigator
Facility Information:
Facility Name
McMaster University
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8S 4L8
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rebecca Leone
Phone
905-525-9140
Email
rleone@mcmaster.ca
First Name & Middle Initial & Last Name & Degree
Thomas J Hawke, PhD
First Name & Middle Initial & Last Name & Degree
Irena A Rebalka, PhD
First Name & Middle Initial & Last Name & Degree
Maureen MacDonald, PhD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Participant data - after deidentification.
IPD Sharing Time Frame
Starting in May 2024
IPD Sharing Access Criteria
Investigators whose proposed use of the data has been approved by an independent internal committee identified for this purpose.

Learn more about this trial

Healthy Outcomes for Muscle With Exercise in T1D

We'll reach out to this number within 24 hrs